Effect of amyloid β on capacitive calcium entry in neural 2a cells

Brain Research Bulletin

Volumn 78, Issue 4-5, 2009, Pages 152-157

  Niu, Ying ^a   Su, Zuqi ^a   Zhao, Chang ^a   Song, Bo ^a   Zhang, Xiufang ^a   Zhao, Nanming ^a   Shen, Xun ^b   Gong, Yandao ^a  

^a TSINGHUA UNIVERSITY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Alzheimer's disease; Amyloid ; Capacitive calcium entry (CCE)

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALCIUM; GAMMA SECRETASE INHIBITOR;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BLOTTING, WESTERN; CALCIUM; CELL LINE, TUMOR; DIPEPTIDES; INTRACELLULAR FLUID; MUTATION; NEURONS; PEPTIDE FRAGMENTS;

EID: 58749084490     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.10.003     Document Type: Article

References (33)

1. Arispe N., Diaz J.C., and Simakova O. Aβ ion channels prospects for treating Alzheimer's disease with Aβ channel blockers. Biochimica et Biophysica Acta 1768 (2007) 1952-1965
2. Arispe N., Rojas E., and Pollard H.B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90 (1993) 567-571
3. Brzyska M., and Elbaum D. Dysregulation of calcium in Alzheimer's disease. Acta Neurobiol. Exp. (Wars) 63 (2003) 171-183
4. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360 (1992) 672-674
5. Glenner G.G., and Wong C.W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122 (1984) 1131-1135
6. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120 (1984) 885-890
7. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A., and Klein W.L. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA. 100 (2003) 10417-10422
8. 2+ in the cytosol and organelles of neutrophils. J. Immunol. Methods 232 (1999) 77-88
9. Herms J., Schneider I., Dewachter I., Caluwaerts N., Kretzschmar H., and Van Leuven F. Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein. J. Biol. Chem. 278 (2003) 2484-2489
10. Hirakura Y., Carreras I., Sipe J.D., and Kagan B.L. Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense. Amyloid 9 (2002) 13-23
11. Jang H., Zheng J., Lal R., and Nussinov R. New structures help the modeling of toxic amyloidbeta ion channels. Trends Biochem. Sci. 33 (2008) 91-100
12. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., and Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
13. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3 (2002) 862-872
14. Leissring M.A., Akbari Y., Fanger C.M., Cahalan M.D., Mattson M.P., and LaFerla F.M. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell. Biol. 149 (2000) 793-798
15. 2+-sensitive channel in reconstituted lipid vesicles. Biochemistry 38 (1999) 11189-11196
16. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 4245-4249
17. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., and Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1 (1992) 345-347
18. Murray F.E., Landsberg J.P., Williams R.J., Esiri M.M., and Watt F. Elemental analysis of neurofibrillary tangles in Alzheimer's disease using proton-induced X-ray analysis. Ciba. Found. Symp. 169 (1992) 201-210
19. Arispe N., and Simakova O. Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers. Biochimica et Biophysica Acta 1768 (2007) 1952-1965
20. Nixon R.A., Saito K.I., Grynspan F., Griffin W.R., Katayama S., Honda T., Mohan P.S., Shea T.B., and Beermann M. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. N. Y. Acad. Sci. 747 (1994) 77-91
21. Onyango I.G., and Khan S.M. Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease. Curr. Alzheimer. Res. 3 (2006) 339-349
22. Parekh A.B., and Putney Jr. J.W. Store-operated calcium channels. Physiol. Rev. 85 (2005) 757-810
23. 2+ entry: evidence for a secretion-like coupling model. Cell 98 (1999) 487-499
24. Quist A., Doudevski I., Lin H., Azimova R., Ng D., Frangione B., Kagan B., Ghiso J., and Lal R. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad.Sci. U.S.A. 102 (2005) 10427-10432
25. 2+-sensitive channel. J. Biol. Chem. 273 (1998) 13379-13382
26. Simakova O., and Arispe N.J. Early and late cytotoxic effects of external application of the Alzheimer's Abeta result from the initial formation and function of Abeta ion channels. Biochemistry 45 (2006) 5907-5915
27. Sokolov Y., Kozak J.A., Kayed R., Chanturiya A., Glabe C., and Hall J.E. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J. Gen. Physiol. 128 (2006) 637-647
28. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos Jr. L., Eckman C., Golde T.E., and Younkin S.G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264 (1994) 1336-1340
29. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126 (2006) 981-993
30. Wang Z.F., Li H.L., Li X.C., Zhang Q., Tian Q., Wang Q., Xu H., and Wang J.Z. Effects of endogenous beta-amyloid overproduction on tau phosphorylation in cell culture. J. Neurochem. 98 (2006) 1167-1175
31. Woods J., Snape M., and Smith M.A. The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. Biochim. Biophys. Acta 1772 (2007) 503-508
32. 2+ oscillations in cultured hippocampal networks. Cell Biol. Int. 30 (2006) 733-740
33. Yoo A.S., Cheng I., Chung S., Grenfell T.Z., Lee H., Pack-Chung E., Handler M., Shen J., Xia W., Tesco G., Saunders A.J., Ding K., Frosch M.P., Tanzi R.E., and Kim T.W. Presenilin-mediated modulation of capacitative calcium entry. Neuron 27 (2000) 561-572